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Depression is a disorder that can affect every aspect of one's life, ranging from 
physical health issues to interpersonal relationship difficulties. Therefore, it is imperative 
that the depressive symptoms of college students be identified, evaluated, and treated. 
Self-report measures are a common technique to identify depressive symptomatology in 
individuals and assist in diagnosis and treatment. Existing measures are often used as a 
criterion by which to validate the psychometric properties and effectiveness of newly 
designed, self-report measures. The purpose of this investigation was to explore the 
concurrent validity of a newly published self-report measure of depression, the Clinical 
Assessment of Depression (CAD; Bracken & Howell, 2004) with an existing measure, 
the Beck Depression Inventory-Second Edition (BDI-II; Beck, Steer, & Brown, 1996). 
The sample used for this investigation consisted of 125 college students (38 males and 87 
females) ranging in age from 18 to 52 years. Internal consistencies for the sample were 
computed for the BDI-II and the CAD and were found to be in the acceptable range with 
computed coefficient alphas from r - .87 to .97. Significant, moderate to strong positive 
correlations were found between the CAD total score and the CAD subscales with the 
BDI-II total score and ranged from .55 to .97. This study also investigated gender 
differences on both measures. Independent f-tests were computed and found no 
significant difference between male and female mean scores on either the CAD or the 
v 
BDI-II. Classification consistency between the CAD diagnosis of depression and the 
BDI-II diagnosis of depression using the BDI-II as the criterion was 82%. The measures 
have high consistency when identifying individuals as falling within a clinically 
significant diagnostic category of depression. Overall, results indicate that the CAD is a 
valid measure of depressive symptomatology in college students. 
vi 
Introduction 
Depression is frequently referred to as the "common cold" of psychological 
disorders as it is a common complaint that brings individuals in for psychological 
treatment. Kessler et al. (2003) compiled prevalence rates from several large 
epidemiological studies estimating the prevalence rate for major depressive disorder. 
They found the prevalence rate to be approximately 16% across the lifespan and 6.5% in 
the last 10 months. Kessler et al. (2003) further substantiated that women are twice as 
likely to have mood disorders as men. Since depression is a common, frequently noted 
psychological disorder, it is important to assess the nature and severity of depression in 
order to appropriately treat the disorder. 
Assessment of psychological disorders, such as depression, typically involves the 
use of interviews and standardized instruments (Camara, Nathan, & Puente, 2000). 
When new standardized measures are developed, it is important to determine their 
effectiveness relative to existing measures. The Clinical Assessment of Depression 
(CAD; Bracken & Howell, 2004) is a newly published measure that purports to assess 
depression across the lifespan. Of interest to this study will be the CAD's ability to 
assess and identify college aged individuals' symptoms of depression relative to an 
existing measure in the field. 
The following literature review will provide a rationale and purpose for 
investigating the validity of the CAD. First, an overview of depression in college 
students will be provided, along with a discussion of gender differences in depression. 
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The diagnostic criteria for unipolor mood disorders will be provided as a basis for 
understanding the assessment of depression. Last, a discussion of the CAD and rationale 
for selection of the criterion measure, the Beck Depression Inventory-II (BDI-II; Beck, 
Steer, & Brown, 1996), will provide a basis for the research questions for this study. 
Review of Literature 
Depression in College Students 
There are approximately 19 million American adults affected annually by 
depression, and college students are not exempt from the disorder. Nearly 10 percent of 
college students arrive on campus with a history and/or diagnosis of depression. Further, 
13 percent of female college students have a history of this disorder (National Mental 
Health Association [NMHA], 2004; UMICH Health System, 2003). Typically the onset 
of depression occurs between the ages of 15 and 19 years, and depression is frequently 
comorbid with other disorders (UMICH Health System, 2003). Blazer, Kessler, 
McGonagle, and Swartz (1994) found that the age groups of 15-to 24-year-olds and 35-to 
44-year-olds were more likely than older individuals to have comorbid depression with 
such psychiatric conditions as phobia, manic episode, nonaffective psychosis, generalized 
anxiety disorder, panic disorder, or substance abuse or dependence. 
College students experience similar symptoms as other adults who have 
depression, but more specifically they experience pleasure and mood problems, tend to 
withdraw from friends and activities that were once considered enjoyable, and have 
difficulty performing academically. In addition, they experience problems concentrating, 
feelings of being overwhelmed, and changes in appetite and sleep patterns. Because of 
the physical distance between college students and their parents, as well as parents' 
possible reluctance to disturb their child's newfound independence by asking about 
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her or his well-being, it is often a student's friend, roommate, or residence hall advisor 
who is the first to become aware of these behavior changes (UMICH Health System, 
2003). 
Undiagnosed and untreated depression can have an adverse impact on college 
students, such as hindering one's ability to work, socialize, achieve academically, and 
enjoy life in general. It can also lead to suicide. In 1998, suicide was the third leading 
cause of death for those ages 15 to 24 and the second leading cause of death for college 
students (NMHA, 2004). Therefore, the non-identification of depression can lead to 
serious, and sometimes life-threatening, consequences. 
Gender and Depression 
When examining the prevalence rates of depression by gender, females are noted 
to experience depressive moods nearly twice as frequently as males (American 
Psychiatric Association [APA], 2000; Blazer et al., 1994; Kelly, Kelly, Brown, & Kelly, 
1999; Kessler, McGonagle, Nelson et al., 1994; Klerman, 1988; NIMH, 2000; Weissman 
et al., 1993). Ratios as high as 3:1 have been noted by some researchers (Klerman & 
Weissman, 1989; Wetzel, 1994). Females have a higher lifetime prevalence rate for 
major depression and dysthymia than males. Specifically, Weissman et al. (1993) found 
females to have a higher rate of major depression (8% compared to 3.5%) than males, as 
well as a higher rate of dysthymia (5.4% compared to 2.6%) in the United States. The 
Cross-National Collaborative Group (Weissman et al., 1996) assessed depression rates in 
10 countries and found that rates of major depression were higher for females than males 
in every country, although the ratio varied from 1.6:1 in Beirut and Taiwan to 3.1:1 in 
West Germany. Although research from Kessler, McGonagle, Zhao et al. (1994) 
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supports the consensus regarding higher rates of depression in females compared to 
males, it indicates that males ages 20 to 30 experience a higher rate of depression than 
females. Although there is some variability among studies regarding the prevalence of 
depression in females in comparison to males, the findings that females experience 
depressive moods nearly twice as often as males appear to be reliable and stable. 
The prevalence rate of depression not only varies between genders but it also 
varies across ages. Depression occurs more frequently in younger individuals, beginning 
in early adolescence, than older individuals (Reinherz, Frost, and Pakiz, 1991). 
According to Cyranowski, Frank, Young, and Shear (2000), there is a general increase in 
rates of depression for adolescent girls ages 11 to 13. By the age of 15, females are twice 
as likely to have experienced a depressive episode as males. Although the reasons for the 
higher rate of depression in females are unclear, some suggestions are provided to 
account for this variability between genders. According to the NMHI study (1997), some 
possible reasons for the higher prevalence rates are that females, in general, may be more 
willing to seek help than males and therefore have a higher number of entries in the 
depression database. Biological differences between females and males may also play a 
role. An updated NIMH (2000) report suggests that hormonal changes associated with 
women's menstrual cycle, pregnancy, and the postpartum period may be related to the 
higher rates of depression in females. Certain psychosocial factors, such as different 
social roles and less favorable economic opportunities, may contribute to this increased 
rate. Also, the interpersonal relationships of females may play a role in their increased 
risk of depression. For example, relationships seem to have a more profound effect on 
the self-concept of females than on males. Furthermore, females are more prone to 
experience distress from negative events in others' lives and place their needs secondary 
to the needs of others (American Psychological Association [APA], 2002). According to 
the American Psychological Association (APA, 2002), the cognitive styles of females can 
contribute to their increased susceptibility to depression. For example, a ruminative 
cognitive style, which is associated with severe and longer episodes of depression and 
more commonly seen in females than males, is the repetitive focus on the symptoms, 
causes, and consequences of distress. Breslau, Schultz, and Peterson (1995) suggest that 
the increased rate of anxiety found in females earlier in life in comparison to males may 
also play a role in the higher risk of female depression. 
While females are twice as likely to experience depression in comparison to 
males, other findings suggest that females report more depressive symptoms and greater 
severity of depressive symptoms than males (e.g., Baron & Campbell; 1993, Casper, 
Belanoff, & Offer, 1996; Kelly et al., 1999). Kelly et al. (1999) performed a study with 
college-age participants and found a significant main effect for gender, F(3,138) = 2.69, 
p < .05, with females scoring higher than males. In a study comparing female and male 
mean scores on the Reynolds Adolescent Depression Scale (RADS) and the Beck 
Depression Inventory (BDI), Baron and Campbell (1993) found that females have higher 
mean scores on discriminating items. A study performed by Casper et al. (1996) also 
found that females reported higher levels of depression than males across race. 
According to Bailey, Wolfe, and Wolfe (1996), Caucasian females report significantly 
higher levels of depression than either African-American or Caucasian males. These 
findings support the view that females, in general, report more depressive symptoms than 
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males. These gender differences in severity of rating may be due to previously 
mentioned factors such as hormones, psychosocial issues, and coping styles. 
Diagnostic Criteria 
For a young adult to be diagnosed with depression, specific criteria of the 
Diagnostic and Statistical Manual of Mental Disorders-4th Edition Text Revision (DSM-
IV-TR; APA, 2000) must be met. There are three types of unipolar depressive disorders 
described in the DSM-IV-TR: (a) Major Depressive Disorder, (b) Dysthymic Disorder, 
and (c) Depressive Disorder Not Otherwise Specified. 
Major Depressive Disorder, a severe form of unipolar depressive disorder, is 
characterized by one or more major depressive episodes. These episodes last for at least 
two weeks and consist of depressed mood and loss of interest in daily activities. To be 
diagnosed with Major Depressive Disorder under the DSM-IV-TR criteria, one must also 
have at least five or more of the following symptoms: "change in weight and/or appetite, 
sleep, and psychomotor activity; decreased energy; feelings of worthlessness or guilt; 
inability to concentrate or make decisions; or frequent thoughts of death and suicide 
ideation" (APA, 2000, p. 356). 
The second form of unipolar depressive disorder, Dysthymic Disorder, is 
considered to have similar yet less severe symptoms than those of Major Depressive 
Disorder. Individuals with this disorder are chronically depressed most days for at least 
two years. Reported as feeling "down in the dumps," individuals diagnosed with this 
disorder must meet at least three of the following symptoms during these depressed mood 
states, according to DSM-IV-TR criteria: "poor appetite and/or overeating; insomnia 
and/or hypersomnia; low energy and/or fatigue; low self-esteem; poor concentration 
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and/or difficulty making decisions; or feelings of hopelessness" (APA, 2000, p. 374). 
Although Dysthymic Disorder is typically considered less severe than Major Depressive 
Disorder, a longitudinal study performed by Klein and Schwartz (2000) reported that 
patients with Dysthymia had more severe mood symptoms, were more likely to make 
suicide attempts, were more likely to be hospitalized, and had more functional 
impairments than those patients with Major Depressive Disorder. 
The third form of unipolar depression, Depressive Disorder Not Otherwise 
Specified, is typically used when a disorder with depressive characteristics does not meet 
the DSM-IV-TR criteria for major depression or dysthymia. An example of Depressive 
Disorder Not Otherwise Specified is minor depression in which the depressive episodes 
last at least two weeks but less than five symptoms are present from the criterion list for 
major depression (APA, 2000). 
Depression is diagnosed from observations or self-reports of at least 5 of the 9 
behavioral indicators included in the diagnostic categories. Behavioral indicators of 
depression cover a wide range of cognitive, affective, and physical symptoms. Because 
of the variability and severity of depression, it is important that instruments used to 
measure depression adequately cover the range of symptoms evident in depression, along 
with being valid and reliable measures. 
Self-Report Measures of Depression 
A diagnosis of Major Depression, Dysthymia, and Depressive Disorder Not 
Otherwise Specified is given after a comprehensive assessment is performed that would 
determine the individual's symptoms and behavior patterns. In addition to observations 
and oral reports, self-report scales are frequently used in the process of a comprehensive 
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psychological assessment and are the focus of this investigation. Self-report measures 
give the individual the opportunity to report her or his internal emotions, thoughts, and 
feelings. The individual can provide more direct, first-hand information regarding her or 
his internal state which may offer more insight about her or his personal experience with 
depression than a third party's observations of symptoms and behaviors. 
Self-report measures, which are typically norm referenced instruments, are 
designed in such a way that the individual responds to a series of questions concerning 
her or his social and/or emotional behavior, and these responses are then compared to a 
population sample. It has been suggested by Martin (1988) that in order for a self-report 
measure to be considered objective, it must have adequate test-retest reliability, 
standardized procedures, adequate validity, and provide normative data for comparison. 
One standardized, self-report measure frequently used to assess depression is the 
Beck Depression Inventory which is currently in its second edition. It was originally 
published in 1961 (Beck, Ward, Mendelson, Mock, & Erbaugh, 1961) and underwent 
amendments in 1979 and was most recently revised as the BDI-II (Beck, Steer, & Brown, 
1996). This self-report measure of depression is one of the 50 most frequently used 
psychological tests used by clinical and neuropsychologists, according to a national study 
by Camara, Nathan, and Puente (2000). 
The BDI-II is a 21-item, self-report measure that assesses the severity of 
depression in individuals aged 13 years and older. The current version was modified to 
assess symptoms which correspond with those of the American Psychiatric Association's 
(APA) Diagnostic and Statistical Manual of Mental Disorders-Fourth Edition (DSM-IV; 
1994) criteria for diagnosing depressive disorders. The BDI-II omitted four previous 
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items (Weight Loss, Body Image Change, Somatic Preoccupation, and Work Difficulty) 
and replaced them with four new items (Agitation, Worthlessness, Concentration 
Difficulty, and Loss of Energy). This change was made to address symptoms typical of 
severe depression or depression which may require hospitalization. Additional 
modifications made to the BDI-II were the adjustment of two items to allow for 
fluctuations in appetite and sleep, as well as the rewording of statements used in rating 
other symptoms (Beck, Steer, & Brown, 1996). 
The BDI-II is one of the most widely used measures among practitioners (Camara 
et al., 2000). It takes approximately 5 to 10 minutes to complete and can be administered 
individually or orally to participants with reading and/or concentration difficulties. 
Participants are asked to select one of 4 statements for each of a group of 21 test items 
that best describes how she or he has been feeling for the past two weeks, including the 
day of the assessment. Items are rated on a 4-point scale, ranging from 0 to 3, and then 
each rating is summed to derive a total score. The maximum total score of the BDI-II is 
63. Total scores of 0 to 13 indicate "Minimal" depressive symptomatology, 14 to 19 
represent "Mild" depressive symptomatology, "Moderate" depressive symptomatology is 
represented by scores of 20 to 28, and total scores of 29 to 63 represent "Severe" 
depressive symptomatology (Beck, Steer, & Brown, 1996). The manual recommends a 
cutoff score of 17 for research purposes, which will be used in the present study. 
Although the BDI-II assists in identifying the presence and degree of depressive 
symptoms, the authors warn that it should not be used as a single, clinical diagnosis 
instrument due to a variety of disorders, such as panic disorder and schizophrenia, that 
may accompany depression (Beck, Steer, & Brown, 1996). 
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According to Arbisi (2001), the BDI-II possesses several strengths. It is an easily 
administered instrument with straightforward interpreted guidelines. The test manual is 
well-written, offering the reader an abundance of information regarding norms, factor 
structure, and nonparametric item-option characteristic curves for each item. The BDI-II 
is built on a strong empirical foundation of almost 40 years of research to support the 
effectiveness of earlier versions. 
Statistics for the BDI-II indicate that it is a reliable and valid measure to assess 
depressive symptoms (Beck, Steer & Brown, 1996; Osman, Kopper, Barrios, Gutierrez, 
& Bagge, 2004; Storch, Roberti, & Roth, 1997). As mentioned, Martin (1988) suggests 
specific criteria are necessary for a measure to be considered an objective tool. The BDI-
II has an established test-retest reliability of .93 (Arbisi, 2001; Beck, Steer, & Brown, 
1996; Farmer, 2001). It has a specific, standardized procedure in which items are given 
to individuals in a consistent manner, and normative data is used for comparison of an 
individual's score to scores of a larger group. Furthermore, the validity of the BDI-II has 
been well established (Beck, Steer, & Brown, 1996; Osman, 2004; Storch et al., 1997). 
Convergent and discriminant validity of the BDI-II has been established by comparing it 
to existing psychological measures, such as the Beck Hopelessness Scale (BHS) and the 
Revised Hamilton Psychiatric Rating Scale for Depression (HRSD-R). The BDI-II was 
found to correlate positively with both the BHS (.68) and the HRSD-R (.71). In general, 
reviewers agree that the BDI-II is a psychometrically sound measure that has been 
improved with its most recent version (Arbisi, 2001; Farmer, 2001). 
Although the BDI-II is considered the 10th most frequently used test by clinical 
psychologists who conduct assessment services (Camara et al., 2000) and is used as the 
12 
criterion measure for this investigation, it does have some weaknesses. As with any self-
report measure, it is possible for an individual to exaggerate her or his presentation. The 
BDI-II does not have a validity scale to gauge for the possible distortion of results 
(Arbisi, 2001). Furthermore, normative samples of the clinical population (suburban and 
urban sections of the Northeastern United States) and non-referred population (Canada) 
were not stratified to be representative of the U.S. population (Arbisi, 2001; Farmer, 
2001). The authors of the BDI-II also failed to examine the test items for gender bias 
(Farmer, 2001). Despite these obvious disadvantages, reviewers generally agree that the 
BDI-II is a psychometrically adequate measure that has been improved with its most 
recent revision (Arbisi, 2001; Farmer, 2001). 
The Clinical Assessment of Depression (CAD), developed by Bracken and 
Howell (2004), is an instrument designed to measure depression in individuals between 
the ages of 8 and 79 years using a single form. The CAD is a 50-item scale with a four-
option response (Strongly Disagree, Disagree, Strongly Agree, and Agree). The CAD 
assesses depressive symptoms on four subscales: Depressed Mood, Anxiety/Worry, 
Diminished Interest, and Cognitive and Physical Fatigue. Specifically, the developers 
focused on obtaining a nationally representative standardization sample and developing 
an instrument that would provide validity scales, as well as symptom-based scales that 
were psychometrically sound. In addition, the developers of the CAD wanted to provide 
a measure that could be used to assess depression across the lifespan. 
The normative population of the CAD was stratified by age, gender, and 
race/ethnicity according to the 2001 census data (Bracken & Howell, 2004). Sampling 
was stratified geographically, although it oversampled the Midwest and undersampled the 
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Northeast. Total score coefficient alpha reliabilities for the standardization sample range 
from .96 to .97 across the age ranges. For the four scales, coefficient alpha reliabilities 
range from .78 to .96 which generally exceed the .90 criterion proposed by Bracken 
(1987) for scales used for diagnostic decision-making. The standard error of 
measurement for the T scores ranges from 2 to 5. Reliability coefficients for gender and 
ethnicity are reported to be strong from .82 and above. Test-retest intervals of 7 to 36 
days and 1 to 51 days for child and adult samples respectively yielded a CAD Total Test 
stability coefficients of .85 and .86, respectively. Confirmatory factor analyses of the 
sample for three age groupings of CAD normative sample yielded a four-factor model 
consistent with the test structure. Thus, the CAD appears to be an improvement over 
existing measures of depression, psychometrically as well as conceptually and 
pragmatically. Information from the test manual suggests that it is more statistically 
sound than previous measures, theoretically more well-defined with the use of its four 
subscales, and it is a brief tool that can be used for all ages. 
Independent research has generally supported the findings of the authors of the 
CAD. Bowers (2004) examined the relationship between the BDI-II and the CAD among 
122 adolescents (22 clinical, 98 nonreferred) and found a significant positive correlation 
coefficient of .77 between the total scores of the BDI-II and the CAD. Tinsley (2004) 
found a significant positive correlation between the CAD and the Reynolds Adolescent 
Depression Scale (RADS, r = .88). Classification consistency between the CAD and the 
BDI-II was 82% and between the CAD and the RADS was 83% for the total sample. 
Coefficient alpha for the CAD for Bowers and Tinsley's sample was strong, r = .98, with 
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item corrected correlations ranging from .81 to .88 for the subscales (Jones, Tinsley & 
Bowers, 2005). 
In summary, both the CAD and the BDI-II are adequate measures of depression; 
however, the CAD appears to have a more superior and stratified sampling population 
and demonstrates a sound factor structure for each scale. Although the BDI-II does have 
weaknesses, it is the most frequently used measure to assess depressive symptoms and, 
therefore, is a reasonable measure to use for comparison. 
Purpose of Present Investigation 
Depression is a high incidence, psychological disorder that can cause an increased 
risk for health and interpersonal problems. Although this disorder is found in both males 
and females, research supports that females experience depressive moods twice as often 
as males (APA, 2000; Blazer et al., 1994; Kelly et al., 1999; Kessler, McGonagle, Nelson 
et al., 1994; Klerman, 1988; NIMH, 2000; Weissman et al., 1993). Further, studies have 
shown that not only do females report more depressive symptoms than males but they 
have a greater severity of depressive symptoms, as well (e.g., Baron & Campbell, 1993; 
Casper, Belanoff, & Offer, 1996; Kelly et al., 1999). Self-report measures are essential 
tools used to assess depression and aid in the diagnosis and treatment of this often 
crippling disorder. One way to judge a new measure is to compare it to an existing 
measure which can validate its usefulness and psychometric properties. The Standards 
for Educational and Psychological Testing (AERA, APA, & NCME, 1999) recommend 
that this comparison occur prior to the new measure's use in the field. As previously 
discussed, the BDI-II is a psychometrically adequate and frequently used measure to 
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assess depression. Therefore, it is reasonable to use the BDI-II as the criterion measure 
to evaluate a new, similar measure-CAD. 
This investigation explored the convergent validity of a newly published self-
report measure of depression , the Clinical Assessment of Depression (CAD),with an 
existing measure, the Beck Depression Inventory-Second Edition (BDI-II). Along with 
concurrent validity, gender differences in scores obtained and classification efficacy of 
the CAD were explored. Specific hypotheses for this investigation were as follows: 
1. A significant positive relationship will be found between the ratings 
obtained on the CAD and the BDI-II for a college population for the total scores on each 
measure and each subscale of the CAD with the total score of the BDI-II. 
2. Higher mean scores will be obtained by females than males on both 
measures. High classification efficacy is defined as classification agreement between the 
BDI-II and the CAD equal to or greater than 80 percent. 




The sample consisted of 125 college students (38 males and 87 females) ages 18 
to 52 from a south central Kentucky university enrolled in undergraduate psychology 
courses in which instructors offered alternative methods for obtaining extra credit. The 
mean age of this sample was 22, and it consisted of 110 Caucasians, 8 African 
Americans, 1 Asian, and 6 Other. The sample also consisted of individuals with a 
previous diagnosis of depression (13), comorbid depression (12), or no previous 
diagnosis (105). Independent samples t tests were used to determine if the number of 
individuals with a prior diagnosis was influencing or biasing the sample. No significant 
difference was found on either of the measures between those with a diagnosis and those 
without a diagnosis of depression (BDI-II t(125) = 2.153, p = .06; CAD t (125) = 1.943, 
p = .06). Therefore, the participants of this study were viewed as one sample, rather than 
placing them into diagnosed and non-diagnosed groups. Data on the BDI-II from five 
female participants were incomplete and had to be excluded from the analyses of this 
study. 
Instruments 
Demographic Form. A demographic form was used to track gender, race, age, 
and history of depression for the sample (see Appendix A). The form also requested 
contact information for each participant. The latter information was obtained in case 
responses indicated a possibility of harm to self. 
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Beck Depression Inventory-Second Edition (BDI-II). The BDI-II is a 21-item, self-report 
inventory that measures symptoms of depression. The current edition is considered to be 
more psychomentrically improved over the previous editions ( Arbisi, 2001; Farmer, 
2001). The reliability of the BDI-II has been shown to be adequate with both clinical and 
nonclinical populations. Internal consistencies for clinical and nonclinical populations 
fall within the .89 and above range (Beck, Steer, Ball et al., 1996; Beck, Steer, Brown et 
al., 1996; Jones, Tinsley & Bowers, 2005, Steer & Clark, 1997). Beck, Steer, and Brown 
(1996) found a test-retest reliability coefficient of .91 over a one-week period. 
Convergent and discriminant validity of the BDI-II was established by comparing 
it to existing psychological measures and examining the factor structure of the scale. 
Convergent validity with strong correlations was reported between the BDI-II with the 
Revised Hamilton Psychiatric Rating Scale for Depression (r = .71) and the Beck 
Depression Inventory (r = .93). Moderate correlations are noted with scales measuring the 
related constructs of anxiety (Hamilton Rating Scale for Anxiety - Revised r = .47) and 
hopelessness (Beck Hopelessness Scale r = .37; Beck, Steer, & Brown 1996). Farmer 
(2001) reports that factor analysis has not yielded consistent findings with respect to the 
factor structure for various populations (Beck, Steer & Garbin, 1988) and that the 
measure is intended to assess one construct and should only be interpreted to assess one 
construct. 
Although the BDI-II is one of the most frequently used measures of depression 
(Camara et al., 2000) and generally evidences sound psychometric properties, it does 
evidence some weaknesses. Arbisi (2001) pointed out that the lack of a validity scale to 
assess for distortions of responses and the lack of a stratified normative population were 
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weaknesses of the BDI-II. Farmer (2001) indicated that the lack of analysis of the items 
for gender bias is a significant problem. Despite these weaknesses, reviewers generally 
agree that the BDI-II is a psychometrically adequate measure that has been improved 
with its most recent revision (Arbisi, 2001; Farmer, 2001). 
Clinical Assessment of Depression (CAD). The CAD (Bracken & Howell, 2004), 
is a 50-item scale that takes approximately 10 minutes for completion. The age range for 
this measure is 8 to 79 years. The CAD assesses depressive symptoms correlating with 
DSM-IV criteria on four subscales: Depressed Mood, Anxiety/Worry, Diminished 
Interest, and Cognitive and Physical Fatigue. The wording and content of items on all 
four subscales are considered appropriate for use across the age span. The CAD was 
designed as a comprehensive instrument that could be used across clinical, educational, 
and research settings. 
Due to the CAD's recent publication, it does not have the history and vast amount 
of supportive research as the BDI-II; however, numerous subsample pilot studies and two 
independent research investigations have provided some evidence of its psychometric 
soundness. According to the Clinical Assessment of Depression Manual (Bracken & 
Howell, 2004), its sound psychometric properties are substantiated by the use of a large, 
diverse, national normative sample. Four normative age levels were used in the 
development of this instrument (i.e., ages 8 to 11 years, 12 to 17 years, 18 to 25 years, 26 
to 79 years) to determine its psychometric properties. The Total Scale score of the CAD 
has coefficient alpha reliabilities that range from .96 to .97 and vary little by age, race, 
and gender. The coefficient alphas for the subscales, which vary somewhat due to 
sample size, are as follows: Depressed Mood, which evidences the highest reliability 
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among the subscales, ranged from .95 to .96; Anxiety/Worry ranged from .83 to .86; 
Diminished Interest ranged from .79 to .86; and Cognitive and Physical Fatigue ranged 
from .82 to .87. In addition, the author reported that confirmatory factor analysis strongly 
support the four subscale structure. Also, the test-retest reliability for the CAD's Total 
Scale score ranged from .81 to .87 with a correlation between the CAD Total Scale score 
and the BDI-II (.71) establishing concurrent validity. 
Independent research was also performed to assist in the support of the CAD as a 
sound measure. A study performed by Bowers (2004) examined the relationship between 
the BDI-II and the CAD among clinical (n=23) and nonclinical (n=99) adolescents, 
which indicated a correlation between the two measures of .77. Tinsley (2004), using the 
same sample as Bowers (2004), analyzed the relationship between the CAD and the 
Reynolds Adolescent Depression Scale (RADS). The correlation between the Total Scale 
scores of the CAD and RADS (r = .88) was slightly higher than that of the CAD and 
BDI-II, as well as the correlations found in both the combined clinical (r = .64) and 
nonclinical (r = .82) adolescent groups used in a validity study with the normative 
sample using the CAD and the RADS (Bracken & Howell, 2004). Tinsley's (2004) 
findings were also consistent with Bower's (2004) results, reporting a classification 
consistency of 83% for the total sample of both the CAD and the RADS. Jones, Tinsley, 
and Bowers (2005) reported coefficient alpha of .98 for the CAD and item corrected 
correlations ranging from .81 to .88 for Bowers (2004) and Tinsley's (2004) sample. 
Based on data presented by the aforementioned studies, the CAD appears to be an 
improvement over existing measures of depression. It has a representative normative 
population and evidence of good reliability across gender, age, and race among both 
20 
clinical and nonclinical groups. Construct validity is evidenced through confirmatory 
factor analysis by its strong intercorrelations between each subscale and total scale 
scores, as well as high correlations with existing measures (BDI-II and RADS). 
Procedure 
Participants were recruited from psychology courses at a south central Kentucky 
University through the Student Study Board in which instructors offered alternative 
methods for obtaining extra credit. The Student Study Board is an electronic 
system which students can access and sign up for research study participation through a 
website. Walk-in participants were also accepted for this study. Once the sign-up 
process was completed, participants received information regarding specific time and 
location for the study. At her or his designated time, each participant individually 
received and was asked to complete a consent form (see Appendix B). Because data 
collection for the present study overlapped with another investigation, the Beck Anxiety 
Inventory (BAI) and the Brief Symptom Index (BSI), along with the BDI-II and the 
CAD, were included in the packet. After consent was obtained, each participant received 
a packet of forms (demographic form [Appendix A], CAD, BDI-II, BAI, and BSI) in 
counter-balanced order to control for order effects. Upon completion of the four scales 
and the demographic form, the participants were asked to return them to the investigator. 
After the packet was returned to the investigator, each participant received a debriefing 
statement (see Appendix C). 
In order to maintain confidentiality, names were kept separate and did not appear 
on the forms. A coding system was used for the forms to facilitate participant 
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identification in the event any responses indicated a clinically significant level of 
symptomatology. Seven participants were identified as having a clinically significant 
response and were asked to meet with the primary investigator in private to discuss her or 
his scores. The primary investigator provided information about depression and a list of 
community resources for further assistance. All procedures for this study were approved 
by Western Kentucky University's Human Subjects Review Board (see Appendix D). 
Results 
This study had three purposes: (a) to examine the relationship between the CAD 
and the BDI-II, (b) to determine whether gender differences, specifically females having 
higher mean scores, exist on both measures, and (c) to explore the classification 
consistency using the BDI-II as the criterion measure. Additional analyses were 
conducted to determine the reliability of each measure for this sample and to determine 
the strength of the correlation of each CAD scale with the CAD Total score when the 
scale items are partialed out. 
Table 1 provides the mean score (M), the standard deviation (SD), and the 
standard error of measurement (SEM) for the raw scores on each measure for the total 
sample and for each gender. To examine the relationship between the BDI-II and CAD, 
Pearson product-moment correlation coefficients were computed for the total raw scores 
for each scale and the subscales of the CAD (i.e., Depressed Mood, Anxiety/Worry, 
Diminished Interest, and Cognitive and Physical Fatigue) with the BDI-II total raw score. 
Using the Bonferoni approach to control for Type I error across the 15 correlations, a p 
value of less than .003 was established for significance. The results of the correlational 
analyses are presented in Table 2. All of the 15 correlations were found to be positive 
and statistically significant which supports the first hypothesis. 
Additional analyses indicate that the CAD has item-total correlations within the 
acceptable range with computed coefficient alphas from r = .87 to .97. Coefficient alpha 
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Table 1 
Descriptive Statistics for the Raw Scores on the CADa and the BDI-II1' 
CAD BDI-II 
Sample N M SD SEM N M SD SEM 
Male 38 93.79 25.55 4.15 38 11.32 8.72 1.42 
Female 87 86.11 21.80 2.34 87 8.26 6.56 .70 
Total 125 88.45 23.17 3.45 125 9.19 7.38 .66 
aClinical Assessment of Depression. bBeck Depression Inventory-Second Edition. 
24 
Table 3 
Correlations of CAD" Total Score and Scales with BDI-Ilb Total Score, Coefficient 
Alphas and Corrected item Total Correlations for the CAD". 
Subscale 1 2 3 4 5 6 
1. CAD Total Score ,97c ,95*(.84) ,89*(.82) ,82*(.79) ,90*(.84) .68* 
2. CAD, Depressed Mood - .96° 76* .78* .78* .63* 
3. CAD, Anxiety/Worry .88° 68* .82* .62* 
4. CAD, Diminished .90° .69* .55* 
Interest 
5. CAD, Cognitive and - - .87c .63* 
Physical Fatigue 
6. BDI-II Total Score - .89c 
Note. Values enclosed in parenthesis represent corrected item total correlations for the 
CAD scale. 
"Clinical Assessment of Depression. bBeck Depression Inventory-Second Edition. 
cValues represent coefficient alpha. 
*p<.003 
25 
for the BDI-II total score was acceptable but lower (r = .89). Corrected item total 
correlation coefficients for each CAD scale were computed correlating each scale with 
the other three CAD scales. All corrected item total correlations were strong ranging 
from r = .79 to r = .84. 
To determine whether gender differences were present, independent samples t-
tests were computed to compare mean scores of females to males for each measure. 
Levene's Test for Equality of Variances was computed due to the unequal number of 
participants in each group and found to be significant (p=.03) for the BDI-II. Therefore, 
the Mest where variances are not assumed to be equal was used. The test for the BDI-II 
was not significant, r(56) = 1.932, p = .06. The CAD results were also found to be 
nonsignificant, ?(123) = 1.717, p = .089. The results indicate no significant gender 
difference on either measure. Thus, hypothesis two was not supported. 
To investigate classification efficacy of the CAD, the BDI-II was used as the 
criterion measure. According to Bracken and Howell (2004), a T-score of 60 should be 
used as the cut-off score to determine depressive symptomatology in the clinically 
significant range. A raw score of 17 was used to indicate a clinically significant score on 
the BDI-II as recommended in the manual (Beck, Steer, & Brown, 1996). A 2 x 2 
contingency table was computed (Table 3) to compare depressed and non-depressed 
classifications for the sample on each measure. The examination of the classifications of 
both measures resulted in aX2 - 22.97, (p < .000) and a classification agreement of 81%. 
The CAD identified 13% of the cases as false positives, classifying individuals to be 
depressed when they are not classified as depressed on the BDI-II, and 6% of the cases as 
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Table 3 
Total Sample Classification Table Between BDI-IF and CADbDiagnosis of Depression 
CAD Classification 
BDI-II Classification Non-depressed Depressed Total 
Non-depressed 70% 13% 83% 
(n=87) (n=16) (n=103) 
Depressed 6% 11% 17% 
(n=8) (n=14) (n=22) 
Total 76% 24% 100% 
(n=95) (n=30) (n=125) 
X2 = 22.97, p < .001 
aClinical Assessment of Depression; depression classification based on T-score > 60. 
bBeck Depression Inventory-Second Edition; depression classification based on raw score 
> 17. 
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false negatives, finding individuals not depressed when they are experiencing depressive 
symptoms, according to the BDI-II. 
Discussion 
The present researcher expected to find a significant positive correlation between 
the CAD Total score and its subscales with the BDI-II. Total scores for each measure 
were expected to yield moderate to high correlations between the two measures. In 
addition, gender differences were to be examined for the CAD and the BDI-II. 
Specifically, females were expected to have higher mean scores than males on both 
measures. Further, classification efficacy was to be examined using the BDI-II as the 
criterion measure. 
To address the first purpose of determining the relationship between the CAD and 
the BDI-II, Pearson product moment correlations were computed for the CAD total scale 
score, CAD Depressed Mood scale, CAD Anxiety/Worry scale, CAD Diminished 
Interest scale, CAD Cognitive and Physical Fatigue scale, and BDI-II total score. The 
correlations between the BDI-II total score and the CAD total score and its four subscales 
were found to be positive and significant ranging from .55 to .68, which were similar to 
the findings of Bowers (r = .64 to .77; 2004) and Bracken and Howell (r =.42 to .73; 
2004). According to Cohen's (1988) effect sizes to determine the strength of 
correlations, all correlations were considered moderate, accounting for 30% to 46% of the 
variance between the two measures. The weakest correlation (.55) was found between 
the BDI-II total score and the CAD Diminished Interest scale score which was slightly 
less than Bowers (2004) weakest correlation (.64) between the BDI-II total score and the 
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CAD Diminished Interest scale score. Bracken and Howell (2004) reported a slightly 
weaker correlation (.42) between the BDI-II total score and the CAD Anxiety/Worry 
scale score. The current examination found the strongest correlation (.68) between the 
BDI-II and the CAD total scores to be slightly lower than Bowers' (2004) and Bracken 
and Howell's (2004) findings (.77 and .70, respectively). 
The correlations between the CAD total score and its subscales were also found to 
be positive and significant, ranging from .68 to .95. The weakest correlation (.68) was 
found between the CAD Anxiety/Worry and Diminished Interest scale scores, while the 
CAD total score and the CAD Depressed Mood scale score was found to be the strongest 
correlation (.95). These findings are quite similar to those of Bracken and Howell (2004) 
with CAD total score and subscale score correlations ranging from .68 to .95, as well. 
Bowers (2004) produced slightly higher correlations ranging from .76 to .97. The 
correlations of the current study were considered moderate to strong, accounting for 
approximately 40% to 90% of the variance between the CAD total score and its subscale 
scores. Further analyses computed corrected item total correlations between each CAD 
scale and the other 3 CAD scales (Depressed Mood, Anxiety/Worry, Diminished Interest, 
and Cognitive and Physical Fatigue) and found strong correlations, as well, ranging from 
.79 to .84 indicating that each scale contributes similar, yet different information to the 
total score. These findings are consistent with those of Jones, Tinsley, and Bowers 
(2005) which reported corrected item total correlations between each CAD scale ranging 
from .81 to .88. In general, these results are consistent with previous findings and 
support the hypothesis that the CAD demonstrates strong concurrent validity with the 
BDI-II. 
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The reliability of the CAD and its subscales were found to be quite strong with 
coefficient alphas ranging from .87 to .96. These results are consistent with Bowers' 
(2004) findings of coefficient alphas ranging from .77 to .97 and Bracken and Howell's 
findings (r = .76 to .90; 2004). The Depressed Mood subscale had the strongest 
reliability (.96) with the overall total score, and the Cognitive and Physical Fatigue 
subscale had the weakest reliability (.87) with the CAD total score. The strong reliability 
between the CAD total score and its subscales indicate that each individual subscale 
loads heavily on the overall total score which provides support that the CAD is a sound 
measure that consistently measures associated constructs. The BDI-II, however, did not 
fair as well regarding reliability. Inter-item analyses were conducted to see how well 
each item loaded on the BDI-II total score and resulted in a coefficient alpha of .89. 
Experts in the field recommend using measures with reliabilities above .90 for 
diagnostic purposes (Bracken, 1987). The reliability of .89 for the BDI-II does not meet 
this recommendation; however, the CAD meets this criterion for the Total, Depressed 
Mood, and Diminished Interest scales. This higher reliability suggests that the CAD best 
meets Bracken's (1987) criterion of .90 internal consistency for a measure used for 
diagnostic purposes. 
The second purpose of this study was to investigate whether gender differences 
exist on both measures, specifically females obtaining a higher mean score than males. 
Independent samples Mests were used to compute any mean gender differences of the 
CAD and BDI-II. The r-test computed for the BDI-II and the CAD found no gender 
differences in mean scores. Although results of this study do not support past research in 
which females report more severe ratings of depressive symptoms than males, this 
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finding is consistent with normative data for the CAD which found no gender differences 
(Bracken & Howell, 2004). 
The final purpose of this study was to analyze the classification efficacy of the 
CAD using the BDI-II as the criterion measure. Using a 2 x 2 contingency table, the 
classification consistency for the total sample was found to be 81%. Although the hit rate 
for the total sample was found to be high, 13% were identified as false positives and 6% 
as false negatives. These findings were consistent with those of Bowers (2004) with a 
total sample classification consistency of 82% between the CAD and the BDI-II (10% 
identified as false positives and 8% identified as false negatives), as well as Tinsley's 
(2004) report of classification consistency of 83% for the total sample of both the CAD 
and the RADS. A false positive, which is a more conservative classification, occurred 
when the BDI-II identified an individual as not depressed and the CAD identified that 
individual as depressed. A false negative, which is a more liberal classification, occurred 
when the BDI-II identified an individual as depressed and the CAD identified that 
individual as not depressed. Although a false positive is still considered an error, it is 
more preventative when diagnosing depression. Therefore the greater percentage of false 
positive makes the CAD a more conservative measure than the BDI-II. 
Limitations 
Although pertinent information can be obtained from the current study, there are 
limitations that may impact the interpretation of the results. For example, small sample 
size, specifically in the male group, may have limited the findings of this study. An 
external threat that may have affected data collection is the sole geographic region in 
which data were collected for this study. The participants were recruited from a south 
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central Kentucky university. Although the sample's ethnicity was representative of the 
region (7% minority), it is not representative of the United States' population as a whole 
and, therefore, may not be generalizable to other geographic regions. 
Implications 
Practical Implications. The findings of this study have strong implications for 
practitioners engaged in psychological assessment. Due to the high incidence rate of 
depression, it is essential to have sound psychometric measures to assess this disorder, 
which are limited in the field of psychology. The current study assists in providing data 
that supports the validity of the CAD and provides support for the use of an additional 
assessment resource which can be used to aid in the diagnosis and treatment of 
depression. This study specifically provides information independent from the test 
publisher regarding the validity of the CAD with college students. Because depression, 
which has been reported to be on the rise in recent years (NMHA, 2004), can have such 
an adverse impact on every aspect of one's life, it is imperative to have valid, reliable, 
and standardized measures by which to assess this disorder for the proper identification 
of depressive symptoms and effective treatment. Experts recommend that measures have 
a reliability of .90 for diagnostic purposes. In a study using a college-age sample 
performed by Beck et al. (1996), results indicated a coefficient alpha of .89. Although 
this is considered a high internal consistency, it does not meet Bracken's (1987) criterion 
for diagnostic purposes. While the BDI-II had reliability below the recommended .90 
level for this sample as well, the CAD reached acceptability (alphawise) for classification 
decisions for the total score and two of the four subscales. Furthermore, the results of 
this study have significant implications for practitioners' longitudinal evaluation of 
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clients. The CAD is designed to facilitate the identification of individuals across the 
lifespan and should be considered a useful tool to monitor the progress of clients. 
Because of this instrument's strong theoretical basis, addressed through the four 
subscales, and broad age range, practitioners will be able to use information from this 
single measure throughout the individual's treatment without the introduction of new, 
possibly incompatible instruments. 
Recommendations for future research. The current study investigated the 
convergent validity between the CAD and the BDI-II, both designed to specifically 
measure depressive symptoms. Future research may want to examine divergent validity 
among various tools that measure a wider range of clinical symptoms including, but not 
limited to, depression. Also, additional evidence of validity should be explored through 
factor analysis which would further substantiate the subscale structure of the CAD. To 
further explore gender differences of depression, future research containing a larger, 
more equal sample size across gender that is pooled from a more generalizable setting 
would be ideal for future research. 
Also, this study focused on a college-age sample consisting of predominantly 
Caucasian individuals in their early twenties. Further research should be conducted 
across various races and ages to obtain additional information regarding depression and 
how well the CAD assesses depression across the lifespan of individuals from different 
ethnic groups. 
Finally, further evidence of the CAD's validity should be explored by examining 
a large, clinical population in comparison to a non-referred sample. By comparing a 
clinical and non-referred population, information could be gathered to determine whether 
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the CAD depicts those who have been diagnosed with depressive disorders as also 
demonstrating depressive symptomatology. 
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Have you ever been diagnosed with a psychological disorder? Circle One Yes No 
If yes, please respond to the following: 
Who made the diagnosis? Family Doctor Counselor 
Social Worker Psychologist 
Psychiatrist 
What was your diagnosis? 
Are you currently under treatment? Check all that apply: Therapy/Counseling 
Medication 









Social and Emotional Weil-Being Study 
Project Title: Emotional Well-Being Study 
Investigators: Elizabeth L. Jones, Ph.D., Shelley Hicks, and Carlie West 
Department of Psychology, 745-4414 
You are being asked to participate in a project conducted through Western Kentucky University 
investigating the usefulness of 4 measures of social and emotional well-being used with young adults. 
Please read the following information carefully. It describes the purpose of the study, the procedure to be 
used, risks, and benefits of your participation and what will happen to the information that is collected from 
you. If you agree to participate in this project, Western Kentucky University requires that you give your 
signed agreement to participate in this project. 
The investigator will explain to you in detail the purpose of the project, the procedures to be used, and the 
potential benefits and possible risks of participation. You may ask him/her any questions you have to help 
you understand the project. A basic explanation of the project is written below. Please read this 
explanation and discuss with the researcher any questions you may have. 
If you then decide to participate in the project, please sign on the last page of this form in the presence of 
the person who explained the project to you. You should be given a copy of this form to keep. 
1. Nature and Purpose of the Project: The purpose of this study is to evaluate a new questionnaire 
designed to assess social and emotional well-being in young adults. 
2. Explanation of Procedures: Upon your consent, you will be asked to complete a packet of 4 
questionnaires concerning your thoughts, feelings, and emotions as they related to your day-to-day 
functioning. It will take approximately 30 minutes to complete these 4 questionnaires. 
3. Discomfort and Risks: There are no physical risks involved in filling out the questionnaires. 
However, answering the items may cause you to feel some emotional discomfort, due to the nature of the 
questions asked. 
4. Benefits: You may be able to receive extra credit for you psychology courses, if you instructor 
offers such credit (be sure to check with your instructor). 
5. Confidentiality: All information collected will be kept strictly confidential and will be accessible 
only to the project staff. In addition, all names will be kept separate from the questionnaires. However, if 
your responses to these questionnaires indicate that you may be of harm to yourself or to other people, the 
researchers will immediately inform you. 
6. Refusal/Withdrawal: Refusal to participate in this study will have no effect on any future 
services you may be entitled to from the University. Anyone who agrees to participate in this study is free 
to withdraw from the study at any time with no penalty. 
7. Questions: Can be directed to the researchers collecting data or to Dr. Elizabeth Jones. Dr. Jones 
can be reached in her office (260 TPH) during her office hours (see schedule on her door) or at (270)745-
4414. 
You understand also that it is not possible to identify all potential risks in an experimental procedure, and 
you believe that reasonable safeguards have been taken to minimize both the known and potential but 
unknown risks. 
Signature of Participant Date 
Witness Date 
THIS PROJECT HAS BEEN REVIEWED AND APPROVED BY 
THE WESTERN KENTUCKY UNIVERSITY HUMAN SUBJECTS REVIEW BOARD 
Dr. Phillip E. Myers, Human Protections Administrator 






Thank you for participating in this research study. This study was designed to examine 
the usefulness of a new measure of depression, the Clinical Assessment of Depression. 
For example, does the Clinical Assessment of Depression measure depression as will as 
other measures in the field such as the Beck Depression Inventory and the Brief 
Symptom Index? If you would like a final copy of the research project, please contact 
Dr. Elizabeth Jones at (270)745-4414, or at the Department of Psychology, Western 
Kentucky University, 1 Big Red Way, Bowling Green, KY 42101. The final copies will 
not be available until after December 1, 2005. 
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WESTERN KENTUCKY UNIVERSITY 
Human Subjects Review Board 
Office of Sponsored Programs 
106 Foundation Building 
270-745-4652; Fax 270-745-4211 
E-mail: Sean.Rubino@wku.edu 
In future correspondence please refer to HS05-087, February 15, 2005 
Dr. Elizabeth Jones 
260 TPH 
Department of Psychology 
WKU 
Dear Dr. Jones: 
Your revision to your research project, "Validity of the Clinical Assessment of Depression," was reviewed 
by the HSRB and it has been determined that risks to subjects are: (1) minimized and reasonable; and that 
(2) research procedures are consistent with a sound research design and do not expose the subjects to 
unnecessary risk. Reviewers determined that: (1) benefits to subjects are considered along with the 
importance of the topic and that outcomes are reasonable; (2) selection of subjects is equitable; and (3) the 
purposes of the research and the research setting is amenable to subjects' welfare and producing desired 
outcomes; that indications of coercion or prejudice are absent, and that participation is clearly voluntary. 
1. In addition, the IRB found that you need to orient participants as follows: (1) signed informed consent 
is required; (2) Provision is made for collecting, using and storing data in a manner that protects the 
safety and privacy of the subjects and the confidentiality of the data. (3) Appropriate safeguards are 
included to protect the rights and welfare of the subjects. 
This project is therefore approved at the Expedited Review Level until December 20, 2005. 
2. Please note that the institution is not responsible for any actions regarding this protocol before 
approval. If you expand the project at a later date to use other instruments please re-apply. Copies of 
your request for human subjects review, your application, and this approval, are maintained in the 
Office of Sponsored Programs at the above address. Please report any changes to this approved 
protocol to this office. A Continuing Review protocol will be sent to you in the future to determine the 




Office of Sponsored Programs 
Western Kentucky University 
cc: HS file number Jones HS05-087 
cc: Shelley Hicks 
cc: Carlie West 
